MRVI experienced substantial deterioration in profitability with gross profit declining meaningfully while revenue dropped 28% year-over-year, indicating severe margin compression.
The dramatic erosion in gross margins suggests significant operational challenges, pricing pressures, or unfavorable product mix shifts that are severely impacting profitability despite more modest revenue declines. The company has also substantially reduced capital expenditures, which may indicate cost-cutting measures but could impair future growth capacity.
MRVI's financial position deteriorated significantly with gross profit declining substantially more than the 28% revenue drop, indicating severe margin compression from $108M to $34M. The company reduced its asset base across most categories, with cash declining 33% to $217M and total assets shrinking 24% to $771M, while stockholders' equity fell 35% to $212M. Capital expenditures were cut substantially from $30M to $13M, suggesting aggressive cost reduction measures in response to the operational challenges.
Gross margin compression — rising input costs, pricing pressure, or unfavorable product mix shift.
Capex reduced 55.7% — investment cycle winding down or capital discipline; may improve near-term free cash flow.
Equity declined sharply — large losses, buybacks, or write-downs reducing book value significantly.
Receivables declined — improved collection efficiency or conservative revenue recognition.
Cash declined 32.7% — significant cash burn or deployment; verify adequacy of remaining liquidity runway.
Current assets declined 31% — monitor working capital adequacy and short-term liquidity.
Revenue softened 28.3% — monitor whether this is cyclical or structural.
Total assets contracted 23.6% — asset sales, write-downs, or balance sheet optimization underway.
Current liabilities reduced — improved short-term financial position and working capital health.
Inventory reduced 19.1% — lean inventory management or demand outpacing supply.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →